Most Recent Articles
Investing Alongside Peter Thiel
Stockholm (HedgeNordic) – In September of 2018, biotech start-up ATAI Life Sciences completed a Series A financing round in the amount of $24.4 million to make psychedelic drugs to treat…
CME Group Macro View
CME Group
Can Supply Keep Pace With Any Demand Spike in 2021?
Pent-up demand for travel could be released next year if vaccines are administered widely, but can major producers reopen their supply spigots fast enough?
A Vaccine's Six Points of Economic Impact
A coronavirus vaccine could impact several areas, such as global trade and inflation.
Oil: Supply-Demand Dynamics as Vaccines Emerge
Could the potential arrival of vaccines next year unleash pent-up demand for oil?
What a Vaccine Could Mean for 2021
The potential arrival of vaccines could make 2021 a transformational year.
Options: More Caution in Nasdaq Than Other Markets
Options show investors breathing a sigh of relief over equity market risks post-election.
Bracing for the Onset of La Niña
A La Niña is forming in the Pacific with the potential to heighten volatility in agricultural markets by affecting crop weather in US, Brazil and Australia.
Round Table Discussion
IPM Adding Muscles in Short-Term Strategies
Stockholm (HedgeNordic) – IPM Informed Portfolio Management (‘IPM’) announced a new hire to spearhead the buildout of Short-Term Strategies. Jasmeet Singh Anand joins the systematic investment manager which has $2…
HFs Running Value-Oriented and RV Strategies to Shine
Stockholm (HedgeNordic) – J.P. Morgan Asset Management has released a report presenting outlooks for all…
Hedge Funds Increasingly Adopting RI: Report
Stockholm (NordSIP) – From niche to mainstream: Responsible Investment and hedge funds, a new report…
Hedge Funds Losing the Crown in Alts Market
Stockholm (HedgeNordic) – Hedge funds remain the largest asset class in the European alternatives market,…
Alternative Risk Premia: Nordic Experiences and Expectations
(Partner Content From Kirstein) – Copenhagen-based consultancy Kirstein in this article outlines institutional investors’ experiences and expectations from investing in alternative risk premia. Results and conclusions are solely based on…
